Cyclacel Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Cyclacel Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $189K, a 47.4% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.11M, a 28.1% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.47M, a 2.19% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.51M, a 30.2% increase from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.16M, a 169% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.47M -$33K -2.19% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $1.51M +$349K +30.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $1.16M +$727K +169% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
2020 $430K -$36K -7.73% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $466K +$135K +40.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $331K +$65K +24.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $266K -$516K -66% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $782K +$37K +4.97% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 $745K -$478K -39.1% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $1.22M +$866K +243% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 $357K -$23K -6.05% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $380K -$502K -56.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-26
2011 $882K -$864K -49.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
2010 $1.75M Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.